These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 32667058)

  • 61. PDB-1 from Potentilla discolor Bunge induces apoptosis and autophagy by downregulating the PI3K/Akt/mTOR signaling pathway in A549 cells.
    Zhang RR; Meng NN; Liu C; Li KL; Wang MX; Lv ZB; Chen SY; Guo X; Wang XK; Wang Q; Sun JY
    Biomed Pharmacother; 2020 Sep; 129():110378. PubMed ID: 32544818
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Shenmai Injection Supresses Glycolysis and Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant A549/DDP Cells via the AKT-mTOR-c-Myc Signaling Pathway.
    Sun Y; Chen Y; Xu M; Liu C; Shang H; Wang C
    Biomed Res Int; 2020; 2020():9243681. PubMed ID: 32685545
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Long non‑coding RNA AK001796 contributes to cisplatin resistance of non‑small cell lung cancer.
    Liu B; Pan CF; Ma T; Wang J; Yao GL; Wei K; Chen YJ
    Mol Med Rep; 2017 Oct; 16(4):4107-4112. PubMed ID: 29067469
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Artesunate exhibits synergistic anti-cancer effects with cisplatin on lung cancer A549 cells by inhibiting MAPK pathway.
    Li W; Ma G; Deng Y; Wu Q; Wang Z; Zhou Q
    Gene; 2021 Jan; 766():145134. PubMed ID: 32898605
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Tumstatin185-191 increases the sensitivity to cisplatin in a cisplatin-resistant human lung adenocarcinoma cell line].
    Wang W; Chen P; Li JL; Pei YF; Shuang QC; Liu CH; Cai S; Liu SK; Zhu LY; Zhou R
    Zhonghua Zhong Liu Za Zhi; 2009 Aug; 31(8):577-81. PubMed ID: 20021943
    [TBL] [Abstract][Full Text] [Related]  

  • 66. MicroRNA-106a targets autophagy and enhances sensitivity of lung cancer cells to Src inhibitors.
    Rothschild SI; Gautschi O; Batliner J; Gugger M; Fey MF; Tschan MP
    Lung Cancer; 2017 May; 107():73-83. PubMed ID: 27372519
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polo-like kinase 1 inhibition diminishes acquired resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer with T790M mutations.
    Wang Y; Singh R; Wang L; Nilsson M; Goonatilake R; Tong P; Li L; Giri U; Villalobos P; Mino B; Rodriguez-Canales J; Wistuba I; Wang J; Heymach JV; Johnson FM
    Oncotarget; 2016 Jul; 7(30):47998-48010. PubMed ID: 27384992
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of Holothurian Glycosaminoglycan on the Sensitivity of Lung Cancer to Chemotherapy.
    Lin C; Zhu X; Jin Q; Sui A; Li J; Shen L
    Integr Cancer Ther; 2020; 19():1534735420911430. PubMed ID: 32202167
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Resistance to Selumetinib (AZD6244) in colorectal cancer cell lines is mediated by p70S6K and RPS6 activation.
    Grasso S; Tristante E; Saceda M; Carbonell P; Mayor-López L; Carballo-Santana M; Carrasco-García E; Rocamora-Reverte L; García-Morales P; Carballo F; Ferragut JA; Martínez-Lacaci I
    Neoplasia; 2014 Oct; 16(10):845-60. PubMed ID: 25379021
    [TBL] [Abstract][Full Text] [Related]  

  • 70. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
    Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT
    Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Influence of Autophagy Inhibition on Lung Adenocarcinoma Cell Migration and Invasion Ability, and Efficacy of Gefitinib.
    Liu Y; Du Y
    Technol Cancer Res Treat; 2021; 20():15330338211049000. PubMed ID: 34657484
    [TBL] [Abstract][Full Text] [Related]  

  • 72. p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer.
    Yassin-Kassab A; Chatterjee S; Khan N; Wang N; Sandulache VC; Huang EH; Burns TF; Duvvuri U
    BMC Cancer; 2024 Feb; 24(1):233. PubMed ID: 38373988
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Extracellular Signal-regulated Kinase (ERK)-dependent Phosphorylation of Y-Box-binding Protein 1 (YB-1) Enhances Gene Expression in Granulosa Cells in Response to Follicle-stimulating Hormone (FSH).
    Donaubauer EM; Hunzicker-Dunn ME
    J Biol Chem; 2016 Jun; 291(23):12145-60. PubMed ID: 27080258
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combination treatment with triptolide and hydroxycamptothecin synergistically enhances apoptosis in A549 lung adenocarcinoma cells through PP2A-regulated ERK, p38 MAPKs and Akt signaling pathways.
    Meng G; Wang W; Chai K; Yang S; Li F; Jiang K
    Int J Oncol; 2015 Mar; 46(3):1007-17. PubMed ID: 25573072
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The Vascular Endothelial Growth Factor-A phosphorylates Murine Double Minute-2 on its Serine 166 via the Extracellular Signal-Regulated Kinase 1/2 and p90 Ribosomal S6 Kinase in primary human endothelial cells.
    Aiken J; Birot O
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1548-54. PubMed ID: 27591897
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Bergamottin isolated from Citrus bergamia exerts in vitro and in vivo antitumor activity in lung adenocarcinoma through the induction of apoptosis, cell cycle arrest, mitochondrial membrane potential loss and inhibition of cell migration and invasion.
    Wu HJ; Wu HB; Zhao YQ; Chen LJ; Zou HZ
    Oncol Rep; 2016 Jul; 36(1):324-32. PubMed ID: 27222242
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Resistin increases cisplatin-induced cytotoxicity in lung adenocarcinoma A549 cells via a mitochondria-mediated pathway.
    Gong WJ; Zhou T; Xu JQ; Huang YF; Xiang LP; Zeng F; Han Y; Lv YN; Zhang Y; Wu SL
    Med Oncol; 2021 Apr; 38(6):65. PubMed ID: 33929634
    [TBL] [Abstract][Full Text] [Related]  

  • 78. ADP sensitizes ZL55 cells to the activity of cisplatin.
    Muscella A; Cossa LG; Vetrugno C; Antonaci G; Marsigliante S
    J Cell Physiol; 2019 Apr; 234(4):4409-4417. PubMed ID: 30144378
    [TBL] [Abstract][Full Text] [Related]  

  • 79. TAZ inhibition restores sensitivity of cisplatin via AKT/mTOR signaling in lung adenocarcinoma.
    Xu W; Wei Y; Li Y; Yin Y; Yuan W; Yang Y; Zhao W; Wu J
    Oncol Rep; 2017 Sep; 38(3):1815-1821. PubMed ID: 28737828
    [TBL] [Abstract][Full Text] [Related]  

  • 80. p90 ribosomal S6 kinase: a potential therapeutic target in lung cancer.
    Poomakkoth N; Issa A; Abdulrahman N; Abdelaziz SG; Mraiche F
    J Transl Med; 2016 Jan; 14():14. PubMed ID: 26791782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.